Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirukumab in Active Rheumatoid Arthritis Despite Methotrexate
NCT00718718Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2008
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of sirukumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Aug 2008; status: completed.
02
Drugs
sirukumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00718718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718718.